Literature DB >> 16960872

Nuclear myosin I is necessary for the formation of the first phosphodiester bond during transcription initiation by RNA polymerase II.

Wilma A Hofmann1, Gabriela M Vargas, Ramaswamy Ramchandran, Ljuba Stojiljkovic, James A Goodrich, Primal de Lanerolle.   

Abstract

The nuclear isoform of myosin, Nuclear Myosin I (NMI) is involved in transcription by RNA polymerase I. Previous experiments showing that antibodies to NMI inhibit transcription by RNA polymerase II using HeLa cell nuclear extract (NE) suggested that NMI might be a general transcription factor for RNA polymerases. In this study we used a minimal in vitro transcription system to investigate the involvement of NMI in transcription by RNA polymerase II in detail. We demonstrate that NMI co-purifies with RNA polymerase II and that NMI is necessary for basal transcription by RNA polymerase II because antibodies to NMI inhibit transcription while adding NMI stimulates transcription. Further investigation revealed that NMI is specifically involved in transcription initiation. Finally, by employing an abortive transcription initiation assay, we demonstrate that NMI is crucial for the formation of the first phosphodiester bond during transcription initiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960872     DOI: 10.1002/jcb.21035

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  29 in total

Review 1.  Nuclear actin and myosins: life without filaments.

Authors:  Primal de Lanerolle; Leonid Serebryannyy
Journal:  Nat Cell Biol       Date:  2011-11-02       Impact factor: 28.824

Review 2.  Nuclear functions of actin.

Authors:  Neus Visa; Piergiorgio Percipalle
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

Review 3.  The long journey of actin and actin-associated proteins from genes to polysomes.

Authors:  Piergiorgio Percipalle
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

Review 4.  Nuclear actin: ancient clue to evolution in eukaryotes?

Authors:  Csaba Bajusz; Péter Borkúti; Ildikó Kristó; Zoltán Kovács; Csilla Abonyi; Péter Vilmos
Journal:  Histochem Cell Biol       Date:  2018-07-17       Impact factor: 4.304

Review 5.  Nuclear actin and myosins at a glance.

Authors:  Primal de Lanerolle
Journal:  J Cell Sci       Date:  2012-11-01       Impact factor: 5.285

6.  Persistent nuclear actin filaments inhibit transcription by RNA polymerase II.

Authors:  Leonid A Serebryannyy; Megan Parilla; Paolo Annibale; Christina M Cruz; Kyle Laster; Enrico Gratton; Dmitri Kudryashov; Steven T Kosak; Cara J Gottardi; Primal de Lanerolle
Journal:  J Cell Sci       Date:  2016-08-02       Impact factor: 5.285

Review 7.  Nuclear Actin: From Discovery to Function.

Authors:  Daniel J Kelpsch; Tina L Tootle
Journal:  Anat Rec (Hoboken)       Date:  2018-11-01       Impact factor: 2.064

8.  Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei.

Authors:  Concetta Ambrosino; Roberta Tarallo; Angela Bamundo; Danila Cuomo; Gianluigi Franci; Giovanni Nassa; Ornella Paris; Maria Ravo; Alfonso Giovane; Nicola Zambrano; Tatiana Lepikhova; Olli A Jänne; Marc Baumann; Tuula A Nyman; Luigi Cicatiello; Alessandro Weisz
Journal:  Mol Cell Proteomics       Date:  2010-03-22       Impact factor: 5.911

9.  Nuclear actin and myosins in adenovirus infection.

Authors:  Beata Fuchsova; Leonid A Serebryannyy; Primal de Lanerolle
Journal:  Exp Cell Res       Date:  2015-07-27       Impact factor: 3.905

10.  Molecular motor MYO1C, acetyltransferase KAT6B and osteogenetic transcription factor RUNX2 expression in human masseter muscle contributes to development of malocclusion.

Authors:  Heather Desh; S Lauren Gray; Michael J Horton; Gwenael Raoul; Anthea M Rowlerson; Joel Ferri; Alexandre R Vieira; James J Sciote
Journal:  Arch Oral Biol       Date:  2014-03-20       Impact factor: 2.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.